These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18091051)

  • 1. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C; Suh J; Stea B; Nabid A; Hackman J
    Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
    J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
    Stea B; Suh JH; Boyd AP; Cagnoni PJ; Shaw E;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1023-30. PubMed ID: 16446056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
    Charpentier MM
    Ann Pharmacother; 2005 Dec; 39(12):2038-45. PubMed ID: 16249270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of efaproxiral in metastatic brain tumors.
    Engel RH; Kaklamani VG
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):477-85. PubMed ID: 16613536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
    Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
    Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
    Shaw E; Scott C; Suh J; Kadish S; Stea B; Hackman J; Pearlman A; Murray K; Gaspar L; Mehta M; Curran W; Gerber M
    J Clin Oncol; 2003 Jun; 21(12):2364-71. PubMed ID: 12805339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
    Rades D; Pluemer A; Veninga T; Schild SE
    Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.